{"id":"W2095234732","doi":"10.1016/j.ygyno.2009.04.034","title":"Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: Results of a multicenter phase II study","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Johnson and Johnson; PharmaMar","keywords":"Medicine; Trabectedin; Nausea; Endometrial cancer; Clinical endpoint; Adverse effect; Internal medicine; Vomiting; Surgery; Population; Phases of clinical research; Chemotherapy; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005954594,0.0003106424,0.001409541,0.0004170615,0.00008292963,0.000004764031,0.0002132872,0.0002446923,0.0038995],"category_scores_gemma":[0.001791677,0.0001963222,0.0004825,0.0009162262,0.0001326481,0.00004542237,0.0000669443,0.0002779957,0.000008591327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007904544,"about_ca_system_score_gemma":0.0004078145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001817763,"about_ca_topic_score_gemma":0.0003715685,"domain_scores_codex":[0.9970208,0.0003448626,0.001211922,0.0005506731,0.0004238183,0.0004479188],"domain_scores_gemma":[0.9973117,0.001100463,0.0006682787,0.0003548821,0.0003270671,0.0002376399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1862054,0.07668749,0.001015681,0.00003908344,0.001200308,0.0002740845,0.002023949,0.000008380446,0.01800087,0.000005823047,0.0004990495,0.7140399],"study_design_scores_gemma":[0.2199959,0.7180359,0.01087646,0.0000639991,0.0007874169,0.00002987015,0.001373185,0.0000355739,0.02020587,0.00003768803,0.02832513,0.0002329661],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890453,0.00242964,0.000002086527,0.001592602,0.001322978,0.002698381,0.0001838519,0.00004676731,0.002678367],"genre_scores_gemma":[0.9964046,0.001304547,0.0002601994,0.0007167663,0.0003093592,0.0001544871,0.00005542969,0.00001389405,0.0007807527],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7138069,"threshold_uncertainty_score":0.9970111,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1144682795704401,"score_gpt":0.4039638388979181,"score_spread":0.2894955593274781,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}